Literature DB >> 4206343

Pathogenicity and immunogenic efficacy of a live attentuated plaque vaccine in vervet monkeys.

A F Hallett, M Isaäcson, K F Meyer.   

Abstract

A live attenuated Yersinia pestis (Pasteurella pestis) vaccine strain designated EV51f, which had been passaged through guinea pigs previously treated with ferrous sulfate, was shown to be pathogenic for African green vervet monkeys (Cercopithecus aethips pygerythrus), but not for guinea pigs. The bacilli multiplied in the monkeys, as shown by positive blood cultures, caused an elevation of white cell counts and rectal temperatures, and resulted in death of 26% (13/50) of animals. Postmortem findings of these animals were typical of bubonic-septicemic plague. This vaccine did not cause deaths in 50 guinea pigs even in doses up to 100 million viable bacilli inoculated subcutaneously. It is suggested that the virulence of an attenuated Y. pestis strain which does not produce pigment on a defined medium containing hemin, but possesses all other known virulence determinants, is dependent on the availability of iron in vivo. The serological response of the monkeys as determined by the hemagglutinating and mouse protective antibodies was high one month after vaccination and also in guinea pigs, as shown by virulent challenge. This antibody level declined in monkeys over a period of nearly 6 months, and a decline in immunity was confirmed by virulent challenge which resulted in the death of 30% of vaccinated monkeys. The level of immunity in monkeys did not appear to be related to the dose of vaccine.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4206343      PMCID: PMC422943          DOI: 10.1128/iai.8.6.876-881.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  [ON STABILIZATION OF THE IMMUNOGENIC PROPERTIES OF GIRARD AND ROBIK EV STRAIN. III. EFFECT OF PASSAGE THROUGH THE ANIMAL BODY AND THE SIGNIFICANCE OF SELECTION OF INDIVIDUAL COLONIES IN IMMUNOGENICITY OF EV STRAIN].

Authors:  E I KOROBKOVA; V N LOBANOV; O R KUZNETSOVA
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1964-02

2.  [IMMUNITY IN PLAGUE. ACQUISITIONS SUPPLIED BY 30 YEARS OF WORK ON THE "PASTEURELLA PESTIS EV" (GIRARD AND ROBIC) STRAIN].

Authors:  G GIRARD
Journal:  Biol Med (Paris)       Date:  1963 Nov-Dec

Review 3.  VIRULENCE OF PASTEURELLA PESTIS AND IMMUNITY TO PLAGUE.

Authors:  T W BURROWS
Journal:  Ergeb Mikrobiol Immunitatsforsch Exp Ther       Date:  1963

4.  Studies on the antibody patterns in pneumonic plague patients.

Authors:  F R McCRUMB; S MERCIER; T H CHEN; K F MEYER; K GOODNER
Journal:  J Infect Dis       Date:  1955 Jan-Feb       Impact factor: 5.226

5.  The chemical basis of the virulence of Pasteurella pestis. II. The toxicity for guinea-pigs and mice of products of Past, pestis.

Authors:  E C COCKING; J KEPPIE; K WITT; H SMITH
Journal:  Br J Exp Pathol       Date:  1960-10

6.  The virulence-enhancing effect of iron on nonpigmented mutants of virulent strains of Pasteurella pestis.

Authors:  T W BURROWS; S JACKSON
Journal:  Br J Exp Pathol       Date:  1956-12

7.  Host specificity of Brazilian strains of Pasteurella pestis.

Authors:  T W Burrows; W A Gillett
Journal:  Nature       Date:  1971-01-01       Impact factor: 49.962

8.  Hepatosplenic abscesses due to Yersinia enterocolitica.

Authors:  A R Rabson; H J Koornhof; J Notman; W G Maxwell
Journal:  Br Med J       Date:  1972-11-11

9.  An evaluation of Pasteurella pestis fraction-1-specific antibody for the confirmation of plague infections.

Authors:  T H Chen; K F Meyer
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

10.  DETECTION OF AN ENZOOTIC PLAGUE FOCUS BY SEROLOGICAL METHODS.

Authors:  D C CAVANAUGH; B D THORPE; J B BUSHMAN; P S NICHOLES; J H RUST
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

View more
  14 in total

1.  Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens.

Authors:  V A Feodorova; L N Pan'kina; E P Savostina; O S Kuznetsov; N P Konnov; L V Sayapina; S V Dentovskaya; R Z Shaikhutdinova; S A Ageev; B Lindner; A N Kondakova; O V Bystrova; N A Kocharova; S N Senchenkova; O Holst; G B Pier; Y A Knirel; A P Anisimov; V L Motin
Journal:  Vaccine       Date:  2009-02-13       Impact factor: 3.641

2.  Evaluation of live attenuated plague vaccines in Praomys (Mastomys) natalensis.

Authors:  A F Hallett
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

Review 3.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

4.  A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.

Authors:  Jian Sha; Michelle L Kirtley; Curtis Klages; Tatiana E Erova; Maxim Telepnev; Duraisamy Ponnusamy; Eric C Fitts; Wallace B Baze; Satheesh K Sivasubramani; William S Lawrence; Igor Patrikeev; Jennifer E Peel; Jourdan A Andersson; Elena V Kozlova; Bethany L Tiner; Johnny W Peterson; David McWilliams; Snehal Patel; Eric Rothe; Vladimir L Motin; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

5.  A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.

Authors:  Wei Sun; David Six; Xiaoying Kuang; Kenneth L Roland; Christian R H Raetz; Roy Curtiss
Journal:  Vaccine       Date:  2011-02-12       Impact factor: 3.641

Review 6.  Plague Vaccines: Status and Future.

Authors:  Wei Sun
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

7.  Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.

Authors:  Bethany L Tiner; Jian Sha; Duraisamy Ponnusamy; Wallace B Baze; Eric C Fitts; Vsevolod L Popov; Christina J van Lier; Tatiana E Erova; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2015-10-07

8.  Model systems to study plague pathogenesis and develop new therapeutics.

Authors:  Matthew B Lawrenz
Journal:  Front Microbiol       Date:  2010-11-04       Impact factor: 5.640

9.  A Recombinant Attenuated Yersinia pseudotuberculosis Vaccine Delivering a Y. pestis YopENt138-LcrV Fusion Elicits Broad Protection against Plague and Yersiniosis in Mice.

Authors:  Amit K Singh; Roy Curtiss; Wei Sun
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.609

10.  Selective Protective Potency of Yersinia pestis ΔnlpD Mutants.

Authors:  S V Dentovskaya; S A Ivanov; P Kh Kopylov; R Z Shaikhutdinova; M E Platonov; T I Kombarova; T V Gapel'chenkova; S V Balakhonov; A P Anisimov
Journal:  Acta Naturae       Date:  2015 Jan-Mar       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.